For pharmaceutical and medical products
|
|
- Egbert Wiggins
- 6 years ago
- Views:
Transcription
1 SALES & MARKETING INSIGHTS Focus Is Fundamental: Using Objective-Based Segmentation to Identify, Target and Influence Your Most Valuable Customers Paul Kraus For pharmaceutical and medical products manufacturers, identifying and targeting the most receptive customers is more critical than ever. While customer segmentation has long been considered an important tool to achieve this, traditional methods have often fallen short in helping companies identify the best targets and take effective action. A more focused and practical approach known as objective-based segmentation can provide healthcare companies with segments that are both highly relevant for product strategy and more readily implemented by the organization as a whole.
2 Introduction For pharmaceutical and medical products manufacturers, identifying and targeting the most receptive customers is more critical than ever. As markets have become increasingly crowded and sales and marketing budgets more limited, there is growing recognition that traditional mass-market promotional strategies have become more costly and less effective. Achieving greater focus, both in terms of the targets identified and the messages and support provided to them, is increasingly fundamental to brand success. While historical prescribing or purchase volumes provide a rough starting point to guide targeting efforts, many other factors now influence which customers are, in fact, the best prospects for a specific product or offering. As health-care decision making has become more complex, differences in customer attitudes toward cost, safety or side effects risk, and specific methods of administration, for example, play an important role in determining opportunity at the individual customer level. The growing influence of payers and the shift toward group practices have introduced new considerations into health-care decisions that can significantly affect the opportunity associated with physicians in these accounts. In this new and dynamic environment, past volume alone can often be an unreliable indicator. Customer segmentation has long been considered an important tool for prioritizing customers and understanding their differential needs. However, traditional segmentation efforts have often fallen short in helping health-care companies effectively identify the best targets and take action. There are several reasons. First, while most approaches are designed to identify homogenous groups of customers, these often do not clearly align with the specific objectives for the brand (for example, predicting the best targets, identifying specific tactics to help drive conversion, etc.). Likewise, the results of these efforts can be difficult to communicate because segments are often defined in very complex ways based on dozens of variables. Lastly, and most important, implementation through the sales force can be a significant challenge. Even in markets with customer-level prescribing or usage data, segments can be difficult to project to 2 ZS Associates
3 the full customer population without substantial rep profiling efforts. Many companies pursuing these efforts have found them difficult to implement in practice. For all of these reasons, a more focused and practical approach is required. In our experience, we have found that an alternative methodology known as objective-based segmentation can often provide companies with an effective way to achieve these benefits that is both highly relevant for product strategy and more readily implemented by the organization as a whole. Objective-Based Segmentation Objective-based segmentation is a powerful but conceptually simple approach that is specifically designed to predict which customers have the highest receptivity and value for a brand. Instead of grouping customers simply on their degree of similarity to one another, as in traditional methods, they are segmented only on those underlying dimensions that best predict their likelihood to use the product. This ensures that the segments identified are truly those most relevant to brand strategy and long-term sales opportunity. The fundamental idea behind this approach is that specific markers can help identify customers who are more likely to be receptive to a given product, because they are reflective of important differences in their attitudes, capabilities or needs. For example, specific types of prior prescribing or purchase behaviors can provide evidence for certain preferences, such as comfort in incurring side effects to achieve higher efficacy, or willingness to overcome managed-care hurdles to use a product of choice. Likewise, differences in practice characteristics or infrastructure such as availability of nursing support can also play a vital role, particularly for products that require significant patient education or practice resources. By taking differences in these factors into account, in addition to market volume, objective-based segments can provide an accurate forward-looking view of which customers are most valuable for the brand. In addition to informing customer value, this approach can also provide specific direction into how marketing tactics can be tailored to address 3 ZS Associates
4 each segment s unique needs. Because the segments are designed to predict customers receptivity to the product, they differ in the specific drivers and barriers they face. This can help provide key insights into their promotional preferences and support needs. For example, if cost sensitivity emerges as an important barrier for a given segment, copay offset programs and formulary status communications can be specifically targeted to this segment. Likewise, for segments in which concern exists around mode of administration, specific patient support programs can be targeted to help offset these challenges. The ability to predict these barriers and tailor programs to address them can make this approach equally relevant in specialty markets such as oncology, in which customer prioritization has traditionally been less of a concern. Perhaps the most important advantage of this approach, however, is that it can be substantially easier to implement in many healthcare markets. As shown in Figure 1, while traditional efforts often define segments based on a long list of differentiating characteristics, objective-based segments are typically identified based on a small number of simple rules. In markets with prescriber-level secondary data, these rules can often be applied using secondary markers, allowing segment identification without the need for substantial rep profiling efforts. In markets without secondary data, segments can often be assigned with a minimum of effort, as the rules require no more than a small number of objective facts about each customer, many of which reps in the field may already know. And lastly, the segments are easy to communicate because they are defined in a way that is simple and intuitive to convey throughout the organization. Figure 1. Summary of Differences: Traditional Clustering versus Objective-Based Approaches Figure ALTERNATIVE 1 SEGMENT DEVELOPMENT APPROACHES ABILITY TO PREDICT BRAND PREFERENCE EASE OF PROJECTION EASE OF COMMUNICATION IMPLEMENTATION / MAINTENANCE Traditional Cluster Approaches Segments reflect customer differences but are not designed to predict preference for a specific product Segments must be projected to the broader market us ing algorithms and rep profiling efforts Segments are defined in complex ways that can be challenging to communicate More difficult as requires significant rep profiling efforts Objective-Based Approaches Segment definitions are specifically designed to predict product preferences When possible, segments are defined based on secondary markers, ensuring maximal projection from the start Segments are defined based on rules that are straightforward to communicate Can often be fed directly into call planning and program targeting efforts 4 ZS Associates
5 CASE STUDY Our client, a midsize pharmaceutical company, faced the challenge of launching a next-generation product in a well-established market for a major chronic, progressive disease state. To maximize the launch, it was critical to identify which physicians the company should target and the amount of promotional resources it should allocate to various groups of customers. The product had efficacy advantages over prior therapies, which the company felt made the product potentially more broadly appealing than the current market leader. But it was unclear which physicians would warrant the most effort and which promotional levers would be required to encourage different types of customers to adopt the product. To identify the most receptive segments, the client engaged us to conduct a survey of its potential targets and measure reactions to a detailed (but blinded) profile for the product. We also captured physician perceptions on a host of other factors that were hypothesized as potential drivers and barriers to usage. These primary data were then linked to secondary data sources at the physician level to connect their stated attitudes to their historical prescribing behaviors and other known characteristics of the practice. Using objective-based techniques, we found that a small number of key drivers proved most predictive of customers intentions to adopt the product, and that these could be captured in a limited set of markers already included in the customer database. Based on these drivers, a segmentation tree was developed that clearly defined the segments using simple, well-defined rules. As shown in Figure 2, several factors predicted receptivity to the product, including their rate of adoption of a previously launched product, their comfort with the mode of administration, their sensitivity to cost and their loyalty to the company for other products in the category. Each of these could be measured directly from the database, based on previously identified markers. 5 ZS Associates
6 Figure 2. Segmentation Tree All Physicians Figure 2 Historical Fast Historical Slow Injectable High Users Injectable Low Users Combo Product Users Combo Product Avoiders Low Generic Share High Generic Share High Company Loyalty Low Company Loyalty SEGMENT 1: Fast Adopting Experts SEGMENT 2: Cost-conscious New Product SEGMENT 3: Oral Therapy Preferrers SEGMENT 4: Combination-friendly Slow SEGMENT 5: Company-Leaning Combo Avoiders SEGMENT 6: Low- Receptivity Laggards LEAST RECEPTIVE MOST RECEPTIVE CASE STUDY The resulting segments were easy to define and intuitive to communicate throughout the organization, and also pointed to clear implications for marketing tactics as well as targeting priority. As illustrated in Figure 3, segments differed on the drivers and barriers for the brand, with the most receptive having many drivers and few barriers, and the least receptive segment having many barriers and few drivers. High-potential physicians in the most receptive segments were clearly the top-priority targets for the brand and were identified as potential advocates to drive broader adoption. At the same time, the least receptive segments were deprioritized since the number of barriers they faced would be very challenging to overcome. For each segment, the specific drivers and barriers provided direct insights to help tailor the right mix of messages and programs. For example, physicians for whom the method of administration was a barrier were targeted for specific patient education and support programs, while those perceiving cost barriers had additional emphasis placed on copay offsets. In this way, the segmentation provided clear action steps that tied to the underlying needs of each group. 6 ZS Associates
7 Figure 3. Drivers and Barriers by Segment Figure 3 SEGMENT 1: Fast Adopting Experts DRIVERS Fast Experience With Class Favor Combos Fewer Safety Concerns With Injectables Lower Cost SEGMENT 2: Cost-conscious New Product Fast Experience With Class Favor Combos Fewer Safety Concerns With Injectables High Cost SEGMENT 3: Oral Therapy Preferrers Fast Lower Cost Favor Combos Fewer Safety Concerns Less w Injectables Prefer Orals SEGMENT 4: Combination-friendly Slow With Injectables Lower Cost Favor Combos Fewer Safety Concerns Slow Less Loyal to Company Products SEGMENT 5: Company-Leaning Combo Avoiders Favor Company Products With Injectables Slow No Experience With Class Avoid Combo Products High Cost SEGMENT 6: Low- Receptivity Laggards Less w Injectables Higher Safety Concerns Slow No Experience With Class Avoid Combo Products High Cost BARRIERS CASE STUDY Most important, because every customer was assigned to a segment, results of the effort could be fed directly into physician targeting and call planning efforts to ensure that resources were prioritized toward those segments that were more likely to be receptive. Segment receptivity was combined with market script volume at the physician level to provide a significantly more accurate valuation than would have been possible using volume alone. As shown in Figure 4, six months after launch, differences in product uptake closely mirrored the predicted pattern across segments. Likewise, subsequent market research validated the key drivers and barriers faced by each segment. Call effort was progressively focused toward the more receptive segments to maximize the return on promotional investment, while less costly channels were pursued with less valuable or receptive customers. In other cases, more significant investments in specific support programs were targeted at highpotential targets with specific attitudinal barriers since their high value warranted focused efforts to overcome these barriers. 7 ZS Associates
8 Figure 4. Customer Penetration by Segment (% Trial After Six Months) 100 Figure % 40 44% 20 0 SEGMENT 1: Fast Adopting Experts SEGMENT 2: Cost-Conscious New Product 19% SEGMENT 3: Oral Therapy Preferrers 11% SEGMENT 4: Combination- Friendly Slow 4% 3% SEGMENT 5: Company- Leaning Combo Avoiders SEGMENT 6: Low-Receptivity Laggards CASE STUDY One final benefit of the approach was that it created a common platform for developing and implementing launch strategy across the organization as a whole. Marketing was able to leverage the segments to understand its customers and develop promotional strategies, while the sales force received clear direction on how to prioritize call efforts and selling tactics. Moreover, the organization adopted a common language for discussing, targeting and tracking its customers over time, which facilitated better alignment and coordination in what might otherwise have been a very complex and disconnected launch process. The result was a highly successful launch, with rapid initial uptake as well as sustained market performance over time. Conclusion As illustrated above, objective-based segmentation can provide companies with a practical and effective tool to help target and influence their most valuable customers. While the case study focused on a new product launch, we have also seen similar benefits for companies looking to maximize their inline brands, particularly in dynamic markets in which customers future potential is uncertain. These situations are increasingly common, particularly in markets that have seen changes in the treatment environment or competitive landscape (for example, new entrants, new indications, increased generic competition or evolving treatment guidelines). 8 ZS Associates
9 As health-care markets continue to become more challenging and promotional resources more scarce, maximizing the impact of every dollar of investment will become essential across all stages of the product life cycle. To achieve this, it will be important to go beyond coarse measures of historical potential to identify the specific markers of product receptivity. At the same time, as health-care customers grow more diverse, promotional efforts will need to be tailored to address their unique drivers, barriers and needs. Tools such as objective-based segmentation provide a timely way for companies to rise to meet this challenge. About the Author Paul Kraus is a Principal with ZS Associates in Princeton, N.J. He has developed strategic insights for major pharmaceutical clients across a wide range of therapy areas, including diabetes, cardiovascular, psychiatric, pain management, virology and women s health care. His experience also spans a broad set of methodologies, including integrated segmentation, brand positioning, demand estimation, performance tracking, treatment process analysis and qualitative research. Paul holds a B.A. in economics from Yale University, and a master s and Ph.D. in marketing from the Kellogg School of Management at Northwestern University. About ZS Associates ZS Associates is a global leader in sales and marketing consulting, outsourcing, technology and software. For almost 30 years, ZS has helped companies across a range of industries get the most out of their sales and marketing organizations. From 20 offices around the world, ZS experts use analytics and deep expertise to help companies make smart decisions quickly and cost-effectively. ZS comprises multiple affiliated legal entities. Learn more at 9 ZS Associates
10 ZS Associates ZS Associates, Inc All Rights Reserved All trademarks within this document are either the property of ZS Associates or their licensors.
ZS Medical Affairs Outlook Report Analysis of Field Medical Growth and Industry Trends
ZS Medical Affairs Outlook Report 2017 Analysis of Field Medical Growth and Industry Trends ZS Medical Affairs Outlook Report 2017 Analysis of Field Medical Growth and Industry Trends Forward by Sarah
More informationPay-for-performance has emerged as a leading strategy
SALES & MARKETING INSIGHTS Medical Device Strategies for Competing in a Pay for Performance Future Pete Masloski Pay-for-performance has emerged as a leading strategy for improving quality and reducing
More informationHow Biosimilars Track a Unique Sales Path:
How Biosimilars Track a Unique Sales Path: Three Case Studies to Help Anticipate Biosimilar Entry in Your Market Judith Kulich and Emily Jin How Biosimilars Track a Unique Sales Path: Three Case Studies
More informationUnlike marketers in other industries, many. How Much Is Your Patient Worth? Using Patient Lifetime Value to Sharpen Your Marketing Strategy
S A L ES & M A R K E TI NG I N SIGHTS How Much Is Your Patient Worth? Using Patient Lifetime Value to Sharpen Your Marketing Strategy Dan Frey and Jean-Jacques Raoult Unlike marketers in other industries,
More informationCustomer Segmentation Does Not Work What's Wrong With It?
Customer Segmentation Does Not Work What's Wrong With It? July 2017 OSG at a Glance Offices in US, EU and Asia Over 700 projects Diverse range of leading Fortune 500 clients Reference-able C-Suite level
More informationA High-Touch Approach to Improving Patient Access. Using field support to navigate reimbursement challenges
A High-Touch Approach to Improving Patient Access Using field support to navigate reimbursement challenges For the brand and reimbursement teams who must develop commercial strategies for the biopharmaceutical
More informationJPMSA JOURNAL OF THE PHARMACEUTICAL MANAGEMENT SCIENCE ASSOCIATION SPRING 2014
JPMSA JOURNAL OF THE PHARMACEUTICAL MANAGEMENT SCIENCE ASSOCIATION SPRING 2014 1 ARTICLE 2 Unlocking the Value of Closed Loop Marketing Analytics to Drive Customer Centricity Pratap Khedkar, Managing Principal,
More informationFor medical products companies, 2012 is shaping up to be the year. ZS s Benchmark Study on Medical Products Companies Commercial Operations
EXECUTIVE SUMMARY ZS s Benchmark Study on Medical Products Companies Commercial Operations For medical products companies, 2012 is shaping up to be the year of mobile customer relationship management (CRM)
More informationFebruary September 11, See, for example, Guidance for Industry on Biosimilars: Q & As Regarding Implementation of the BPCI Act of 2009:
February 2014 Biosimilars: Strategic considerations for interchangeability The future timing, magnitude, and impact of the anticipated biosimilar wave continue to be in flux. Major biopharmaceutical manufacturers
More informationTrinity ConTRact: Cornerstone Projects in Contracting Strategy
Trinity ConTRact: Cornerstone Projects in Contracting Strategy With mounting external pressures limiting access and tightening reimbursement, effective contracting is critical to the commercial success
More informationThe End of Spray and Pray : How Pharma Companies Can Market More Effectively by Understanding the Preferences of Individual Doctors
AffinityMonitor TM 2015 Executive Summary The End of Spray and Pray : How Pharma Companies Can Market More Effectively by Understanding the Preferences of Individual Doctors AffinityMonitor TM 2015 Executive
More informationDefining the true market
Defining the true market Case study: How real-world data and outcomes improved a major pharmaceutical company s launch strategy Cardinal Health Specialty Solutions Competing in a crowded marketplace A
More informationConnecting with patients. Digital engagement leads the way to stronger relationships
Connecting with patients Digital engagement leads the way to stronger relationships Connecting with patients / Digital engagement leads the way to stronger relationships Executive summary Connecting with
More informationPRESCRIBING GROWTH IN PHARMA WITH DATA SCIENCE
PRESCRIBING GROWTH IN PHARMA WITH DATA SCIENCE By Troy Andre, Ethan Dabbs, Roman Geis, Erin George, and Martha Pease In an increasingly dynamic environment, pharma brand teams frequently struggle to gain
More informationPhysician Marketing & Outreach Growing Referring Physician Lifetime Value
Growing Referring Physician Lifetime Value Gelb, An Endeavor Management Company 1011 Highway 6 South P + 281.759.3600 Suite 120 F + 281.759.3607 Houston, Texas 77077 www.gelbconsulting.com Overview Today
More informationKEY CONSIDERATIONS FOR EXAMINING CHANNEL PARTNER LOYALTY AN ICLP RESEARCH STUDY IN ASSOCIATION WITH CHANNEL FOCUS BAPTIE & COMPANY
KEY CONSIDERATIONS FOR EXAMINING CHANNEL PARTNER LOYALTY AN ICLP RESEARCH STUDY IN ASSOCIATION WITH CHANNEL FOCUS BAPTIE & COMPANY NOVEMBER 2014 Executive summary The changing landscape During this time
More informationsmarter solutions better adherence improved results
smarter solutions better adherence improved results Medication non-adherence is a big problem Costs the healthcare system roughly $300 billion Prescription Adherence Rates Significant drop in adherence
More informationAt Microsoft, partner satisfaction drives much of the
SALES & MARKETING INSIGHTS How Microsoft Leverages Channel Analytics and Insights to Navigate Today s Changing Partner Business Models by John DeSarbo and Erik Long, ZS Associates At Microsoft, partner
More informationWHITE PAPER. Engaging the Evolving Stakeholder Network: A New Approach for Medical Affairs
Engaging the Evolving Stakeholder Network: A New Approach for Medical Affairs 1 Executive Summary In today s complex healthcare landscape, the success or failure of a new therapeutic intervention depends
More informationInsights into the Evolving Pricing & Market Access Environment
Insights into the Evolving Pricing & Market Access Environment UBC Global Market Access Survey July 2012 JULY 2012 GLOBAL MARKET ACCESS SURVEY UBC s Global Market Access Survey: Setting the Stage For those
More informationMedical products companies recognize the potential. Building a Sustainable Targeting Capability in Medical Device Companies
SALES & MARKETING INSIGHTS Building a Sustainable Targeting Capability in Medical Device Companies A powerful lever to improve top- and bottom-line performance By Bret Caldwell and Brian Chapman Medical
More informationFour entry strategies for small and midsized companies
White paper >7,100 sales reps >220 product launches in 20 countries supported since 2009 Emerging markets: Four entry strategies for small and midsized companies Executive summary Emerging markets offer
More informationUtilize Real World Data to Optimize Patient Savings Programs. Mason Tenaglia Vice President, IMS Institute, Payer and Managed Care Insights
Utilize Real World Data to Optimize Patient Savings Programs Mason Tenaglia Vice President, IMS Institute, Payer and Managed Care Insights September 2018 0 Today we will answer three major questions 1.
More informationProject Destiny Summary
Project Destiny Summary The American Pharmacists Association (APhA), the National Association of Chain Drug Stores (NACDS), and the National Community Pharmacists Association (NCPA) have joined together
More informationBringing patients into focus
Health Care Of special interest to Health care executives Insights for 5executives Bringing patients into focus Using analytics to create a 360-degree view The patient is again becoming the focus of the
More informationArtificial Intelligence in Life Sciences: The Formula for Pharma Success Across the Drug Lifecycle
Volume XX, Issue 60 Artificial Intelligence in Life Sciences: The Formula for Pharma Success Across the Drug Lifecycle Artificial intelligence (AI) has the potential to transform the pharmaceutical industry.
More informationMaximizing Market Access: THE 5 MOST CRITICAL QUESTIONS TO ASK WHEN LAUNCHING A SPECIALTY DRUGS
Maximizing Market Access: THE 5 MOST CRITICAL QUESTIONS TO ASK WHEN LAUNCHING A SPECIALTY DRUGS by Jan Nielsen, division president, Access & Patient Support Are You Asking the Right Questions? We ve all
More informationYASHAJIT SAHA & ABHISHEK SHARMA, SUBJECT MATTER EXPERTS, RESEARCH & ANALYTICS ADVANCED ANALYTICS: A REMEDY FOR COMMERCIAL SUCCESS IN PHARMA.
YASHAJIT SAHA & ABHISHEK SHARMA, SUBJECT MATTER EXPERTS, RESEARCH & ANALYTICS ADVANCED ANALYTICS: A REMEDY FOR COMMERCIAL SUCCESS IN PHARMA wns wns ADVANCED ANALYTICS: A REMEDY FOR COMMERCIAL SUCCESS IN
More informationIDC MarketScape: Worldwide Life Science Social Media Analytics 2017 Vendor Assessment
IDC MarketScape IDC MarketScape: Worldwide Life Science Social Media Analytics 2017 Vendor Assessment Michael Townsend THIS IDC MARKETSCAPE EXCERPT FEATURES: GENPACT IDC MARKETSCAPE FIGURE FIGURE 1 IDC
More informationPowering the Life Sciences Commercial Engine with Market Access Insights
Powering the Life Sciences Commercial Engine with Market Access Insights April 2017 CONTENTS 1. Introduction 3 2. The Race for Market Access Insights has Begun 4 3. Life Sciences is Not Yet Firing on All
More informationSmarter Commerce for healthcare and life sciences
IBM Smarter Commerce Healthcare and Life Sciences Smarter Commerce for healthcare and life sciences Competing in a consumer-centric world 2 Smarter Commerce Across the healthcare ecosystem, from payers
More informationThe BIG question: What s different about a customer-driven business transformation?
The BIG question: What s different about a customer-driven business transformation? With customers holding more power than ever before, some transformation leaders are using the customer perspective to
More informationThe Challenge of Pricing Combination Therapies
The Challenge of Pricing Combination Therapies By David Greber and Srikant Vaidyanathan The role of combination therapies in medicine continues to grow. For the treatment of HIV/AIDS, cancer, and hepatitis
More informationUsing business intelligence for strategic advantage in REMS Received (in revised form): 23 rd November 2010
Original article Using business intelligence for strategic advantage in REMS Received (in revised form): 23 rd November 2010 Ashwin Mathias is a manager at ZS Associates. He has 8 years of experience in
More informationDEMONSTRATING YOUR MEDICINE S VALUE TO ALL STAKEHOLDERS TRUSTED COMMERCIALIZATION AND MARKET ACCESS EXPERTISE
CATALYSTS DRIVING SUCCESSFUL DECISIONS IN LIFE SCIENCES DEMONSTRATING YOUR MEDICINE S VALUE TO ALL STAKEHOLDERS TRUSTED COMMERCIALIZATION AND MARKET ACCESS EXPERTISE WHEN COMMERCIALIZING A MEDICINE, IT
More informationChapter Two Market Segmentation
Chapter Two Market Segmentation Learning Objectives: To understand; 1. What is the meaning of market segmentation 2. What are the benefits and limitations of market segmentation 3. What demographic segmentation
More informationA spec i a l r e p o r t w ri t t e n i n a s s o c i at i o n w i t h I M S
A spec i a l r e p o r t w ri t t e n i n a s s o c i at i o n w i t h I M S Playing to WIN in the Dynamic Market Issues and Considerations for Enhanced Commercial Effectiveness CChange is in the air.
More informationAligning internal teams to secure buy-in from external stakeholders: a critical part of launch strategy
October 2015 Aligning internal teams to secure buy-in from external stakeholders: a critical part of launch strategy The commercial success of a new pharmaceutical product depends on the buy-in of disparate
More informationSEGMENTATION BENEFITS OF SEGMENTATION
SEGMENTATION BENEFITS OF SEGMENTATION Segmentation is an analytical process that identifies key segments within a target market and determines which segments are of higher or lower priority for a brand.
More informationEnterprise Voice Transformation: Migration from TDM to IP
White Paper Enterprise Voice Transformation: Migration from TDM to IP Sponsored by: AT&T Amy Lind February 2018 IDC OPINION Voice has been the primary method of business communication for more than a century.
More informationWanted Dead or Alive: Healthcare Brand Positioning Conceptual and Methodological Considerations
Wanted Dead or Alive: Healthcare Brand Positioning Conceptual and Methodological Considerations Ted Felix, President and Michael Tucker, Ph.D., Senior Vice President SciMedica Group Marketing Research
More informationWhy IT Does Matter in BPO
1 Why IT Does Matter in BPO Information Technology s Key Role in the Success of Business Process Outsourcing By Stan Lepeak and Lee Ann Moore, EquaTerra Large organizations moving to outsource any of their
More informationIDEA TO IMPACT: Guide to Introduction and Scale of Global Health Innovations. Toolkit Overview
IDEA TO IMPACT: Guide to Introduction and Scale of Global Health Innovations Toolkit Overview v1.0, 2015 Context/Disclaimer These templates, examples, and tools have been compiled to provide some inspiration
More informationBIOTECH, MED DEVICE & PHARMA
WHITEPAPER Key Account Management Strategies for BIOTECH, MED DEVICE & PHARMA INTRODUCTION Changes in the healthcare landscape have led to changes in customers. In an environment where healthcare providers
More informationTracking and Measuring Physician Relations
Tracking and Measuring Physician Relations experience. insight. impact. Using Technology For Greater Success By Allison McCarthy, MBA Tracking and measuring the success of physician relations program has
More informationExecution Excellence: The Competitive Frontier for Value-Based Strategies
SALES & MARKETING INSIGHTS Execution Excellence: The Competitive Frontier for Value-Based Strategies Michael B. Moorman T hough savvy sales and marketing executives have been seeking ways to stress value
More informationFrom Volume to Value: Using payer insights to increase sales effectiveness
From Volume to Value: Using payer insights to increase sales effectiveness by Anita Burrell The collective will of the provider community has moved to acquiescence to the payer will controlling costs and
More informationWhy Conduct a Consumer Survey?
Why Conduct a Consumer Survey? Because informed decision-making produces better results RKM Research and Communications, Inc., Portsmouth, NH. All Rights Reserved. Executive summary This paper discusses
More informationACCENTURE HOME 2.0. Helping Communications Service Providers Capture New Opportunities in Living Services
ACCENTURE HOME 2.0 Helping Communications Service Providers Capture New Opportunities in Living Services ACCENTURE HOME 2.0: HELPING COMMUNICATIONS SERVICE PROVIDERS CAPTURE NEW OPPORTUNITIES IN LIVING
More informationORACLE CRM ON DEMAND LIFE SCIENCES EDITION
ORACLE CRM ON DEMAND LIFE SCIENCES EDITION The changing nature of the Life Sciences Industry continues to challenge Life Science sales representatives to become more efficient, more knowledgeable and approach
More informationData and Analytics Unlocking Future of Pharma Sales Planning. Maria Kliatchko
Data and Analytics Unlocking Future of Pharma Sales Planning Maria Kliatchko Data and Analytics Unlocking Future of Pharma Sales Planning Maria Kliatchko The only thing constant is change. But while competitive
More informationIntuition, experience and conventional marketing frameworks. MarketLive: Better Marketing Strategy Through Patient Journey Simulation
SALES & MARKETING INSIGHTS MarketLive: Better Marketing Strategy Through Patient Journey Simulation Jean-Jacques Raoult, Amy Marta and Maneesh Gupta Intuition, experience and conventional marketing frameworks
More informationFrom discussion to implementation: How to negotiate and implement a risk-sharing agreement
July 2017 From discussion to implementation: How to negotiate and implement a risk-sharing agreement At the table with payers and manufacturers Background The groundswell of interest in value-based drug
More informationOptimal Strategix Group: An Introduction
Optimal Strategix Group: An Introduction November 6, 2013 2013 No part of Optimal this publication Strategix may Group be reproduced, www.optimalstrategix.com stored in a retrieval system, or transmitted
More informationUNLOCK Profit Potential
UNLOCK Profit Potential 26 MM May/June 2007 Reprinted with permission from Marketing Management, May/June 2007, published by the American Marketing Association. Align marketing with financial performance.
More informationWHITEPAPER OPTIMISE YOUR BRAND AND MARKETING STRATEGY WITH BRANDPOINT
WHITEPAPER OPTIMISE YOUR BRAND AND MARKETING STRATEGY WITH BRANDPOINT INTRODUCTION Do you know how your brand is perceived among your core customers? Or why consumers are choosing your products over a
More informationDynamic Prescriber Pull-Through Messaging Proven Effective at Growing Share
Dynamic Prescriber Pull-Through Messaging Proven Effective at Growing Share Targeted pull-through messages demonstrated to be more effective with increased frequency A PRECISION BRIEF Introduction Healthcare
More informationShifting Pharma Sales Models. Text for a pull out can go heretext for a pull out can go heretext for a pull out can go
Text for a pull out can go heretext for a pull out can go heretext for a pull out can go Text for a pull out can go here Text for a pull out can go here Shifting Pharma Sales Models to Focus on Providing
More informationDefining Strategic Metrics to Demonstrate Impact
The Value of Medical Affairs: Defining Strategic Metrics to Demonstrate Impact www.envisionpharmagroup.com The Value of Medical Affairs: Defining Strategic Metrics to Demonstrate Impact Objectives Establish
More informationTransforming HR to Meet New Business Priorities
Transforming HR to Meet New Business Priorities HR transformation efforts are continuing to shift their focus to business priorities, concentrating on areas such as talent, emerging markets, and the HR
More informationFoodservice Category Management. Better Insights. Enhanced Collaboration. Maximum ROI
Foodservice Category Management Better Insights. Enhanced Collaboration. Maximum ROI Changing Dynamics in the Foodservice Industry The foodservice industry today is in a state of intense competition and
More informationStrategic Plan. Uniting to care & cure
2017-2020 Strategic Plan Uniting to care & cure Table of Contents Message from the President & CEO Page 2 Overview Page 3 Mission Page 4 Core Values Page 5 2017-2020 Objectives & Strategies Page 6 Mission
More informationMarket Access. Just a new buzzword? - or - A fundamental change in doing business? Market Access Position Paper April 11
Market Access Just a new buzzword? - or - A fundamental change in doing business? Copyright 2011 pharmalevers GmbH all rights reserved Page 1 It is a challenging question of whether market access is just
More informationSTRATEGIC PRIORITIZATION AND DESELECTION
PUBLICATION SNAPSHOT Transformative Planning: STRATEGIC PRIORITIZATION AND DESELECTION The multiple moving parts in today s health care landscape, particularly the erosion of a favorable payer mix, have
More informationPolicy principles for a competitive healthcare environment
Policy principles for a competitive healthcare environment Pharmaceutical Research and Development Industry Malta Association (PRIMA) PRIMA is an affiliate of the European Federation of Pharmaceutical
More informationPharma Marketing Tool Box
Jean-Michel Peny Pharma Marketing Tool Box 2 nd Revised & Augmented Edition A division of Smart Pharma Consulting 1 Contents Introduction p. 16 Structure of the Pharma Marketing Tool Box p. 16 Marketing
More informationKristin Peck. John Young. Pfizer: Think Digital First. An interview with. EVP WW Business Development and Innovation, Pfizer
An interview with Kristin Peck EVP WW Business Development and Innovation, Pfizer John Young President and General Manager Primary Care, Pfizer Pfizer: Think Digital First Transform to the power of digital
More informationAn integrated model approach to improve the management of marketed products
Insight brief Regulatory and safety integration An integrated model approach to improve the management of marketed products Leo Dodds, Principal, Quintiles Advisory Services John Rogers, Engagement Leader,
More informationMarketing Data Solutions for the Financial Services Industry
Marketing Data Solutions for the Financial Services Industry Maximize your revenue with better data. Publication Date: July, 2015 www.datamentors.com info@datamentors.com 01. Maximize Revenue with Better
More informationB2B Marketing Trends Report
B2B Marketing Trends Report December 2017 Page 1 FOREWORD An ever-shifting landscape In the endless search for a competitive edge, it s easy to get caught up in the hype surrounding new marketing trends
More informationMARKET RESEARCH AT ADELPHI SEPTEMBER 2016
MARKET RESEARCH AT ADELPHI SEPTEMBER 2016 Adelphi Research conducts primary market research, exclusively in the healthcare industry Parent Company: Omnicom Group Providing full-service primary custom marketing
More informationDIGITAL EDITION BONUS CONTENT
DIGITAL EDITION BONUS CONTENT Denise Myshko Forecasting Pharma s Future Given the volatility of today s financial landscape, c ompanies, more than ever, need a robust forecasting strategy that is clear,
More informationMarketing Accountability
Marketing Accountability Critical success factors for greater marketing effectiveness and efficiency Marketing is increasingly under pressure to make the most of its brands, its investments, and its organization.
More informationUtility. Commercial Customer Engagement: The Five Analytics Strategies
Utility Commercial Customer Engagement: The Five Analytics Strategies Introduction Historically, the utility-commercial customer relationship has been relatively simple: the utility supplies reliable power
More informationSMB s using BI to gain a competitive
SMB s using BI to gain a competitive edge Eight advantages that BI brings to your business sales and marketing efforts The business value that business intelligence (BI) provides is the enhanced capability
More information2018 North American Real-World Evidence Enterprise Solutions Market Leadership Award
2018 North American Real-World Evidence Enterprise Solutions Market Leadership Award 2018 2018 NORTH AMERICAN REAL-WORLD EVIDENCE ENTERPRISE SOLUTIONS MARKET LEADERSHIP AWARD Contents Background and Company
More informationACHIEVING COMPETITIVE ADVANTAGE WITH ANATOMY AND PHYSIOLOGY
Pioneering the Exploration of the Human Body ACHIEVING COMPETITIVE ADVANTAGE WITH ANATOMY AND PHYSIOLOGY The healthcare and life sciences industries are becoming more crowded each day, as companies compete
More informationThe New Role of Medical Affairs in Defining and Driving Product Success
The New Role of Medical Affairs in Defining and Driving Product Success Suma Ramadas, PhD, and Susan Suponcic, PhD Syneos Health Consulting 2018 Syneos Health. All rights reserved. The Organizational Role
More informationMEETING THE INCREASING REQUIREMENTS FOR HUMAN FACTORS CONSIDERATIONS
MEETING THE INCREASING REQUIREMENTS FOR HUMAN FACTORS CONSIDERATIONS Human factors engineering (HFE) is now an essential requirement for all new drug delivery combination product approvals to ensure devices
More informationAshfield Commercial. Commercial & Medical Services. INSIGHT & PERFORMANCE Business Edge InforMed Insight Pharma Marketing Academy
COMMERCIAL Ashfield In2Focus Pharmexx Ashfield Commercial Ashfield Healthcare Ireland Ashfield KK Expansis Ashfield MCG CLINICAL Ashfield In2Focus Pharmexx Ashfield Healthcare Ashfield Healthcare Ireland
More informationSeven Key Success Factors for Identity Governance
WHITE PAPER Seven Key Success s for Identity Governance Insights and Advice from Real-World Implementations You have been given a high-profile mission: address urgent audit and compliance requirements
More informationCustomer Lifecycle Management How Infogix Helps Enterprises Manage Opportunity and Risk throughout the Customer Lifecycle
Customer Lifecycle Management How Infogix Helps Enterprises Manage Opportunity and Risk throughout the Customer Lifecycle Analytics can be a sustained competitive differentiator for any industry. Embedding
More informationDoctors to Pharma: Let s Get Personalized
Doctors to Pharma: Let s Get Personalized How to deliver high-quality messaging that s tailored to physician preferences By Malcolm Sturgis Doctors to Pharma: Let s Get Personalized How to deliver high-quality
More informationAgile Master Data Management
A better approach than trial and error by First San Francisco Partners 2 Common MDM initiative and benefit Customer Optimization Improve up-sell, cross-sell and customer retention Access full-customer
More informationMaximizing the. Strategic Planning Community Collaboration Grant Management Staff Management
Page 1 Maximizing the A comprehensive guide to using the Results Scorecard for: Strategic Planning Community Collaboration Grant Management Staff Management By JaNay Queen, Ph.D. Director of Client Services
More informationOptum Performance Analytics
Optum Performance Analytics A unified health care data and analytics platform Photo to come Optum Performance Analytics Position your organization for success with Optum Performance Analytics Dynamic health
More informationSeven Keys to Customer Retention Jorge A. Restrepo M.G.A. EurekaFacts LLC
Seven Keys to Customer Retention Jorge A. Restrepo M.G.A. EurekaFacts LLC It takes far more effort to acquire a new customer than to retain one, says the old business adage. And the benefits can be far
More informationTerritory alignment management is at the heart of any
S A L ES & M A R K E TI NG I N SIGHTS Solving the Territory Alignment Management Challenge: Balancing the Need for Local Decision Making With Centralized Coordination Sandra Forero and Maria Kliatchko
More informationAchieving customer intimacy with IBM SPSS products
Achieving customer intimacy with IBM SPSS products Transformative technologies for the new era of customer interactions Highlights: Customer intimacy is an innovative strategy for helping organizations
More informationFinancial Services: Maximize Revenue with Better Marketing Data. Marketing Data Solutions for the Financial Services Industry
Financial Services: Maximize Revenue with Better Marketing Data Marketing Data Solutions for the Financial Services Industry DataMentors, LLC April 2014 1 Financial Services: Maximize Revenue with Better
More informationTechniques A practical path to customer loyalty
Techniques A practical path to customer loyalty The author is a Director of Customer Value Management, Fixed Wireless Access Division, Paignton, UK. Abstract Describes, utilising practical examples/results,
More informationMARKETING (MKT) Marketing (MKT) 1
Marketing (MKT) 1 MARKETING (MKT) MKT 201. Foundations of Marketing. 3 Credit Understanding and satisfying consumer need through product planning, pricing, promotion, and distribution. Students identify
More information2012 Healthcare (Pharmaceutical) Industry Perspective
2012 Healthcare (Pharmaceutical) Industry Perspective In keeping with our tradition, we pause to reflect on the critical issues the pharmaceutical industry will face in 2012 and how life sciences companies
More informationOptum Performance Analytics
Optum Performance Analytics A unified health care data and analytics platform Photo to come Dynamic health care market forces, fueled by delivery and payment reform, have posed many new and difficult questions
More informationThe Face of the Bank. Leveraging Your Web Portal as a Differentiator
The Face of the Bank Leveraging Your Web Portal as a Differentiator 2 Introduction Today s banking experience is vastly different for corporations than it has been in the past. Customer experience, rather
More informationThe Importance of B2B Brand Strategies
The Importance of B2B Brand Strategies A brand is a brand is a brand. Right? Not so fast. We're all familiar with the consumer brands that we incorporate into our lives on a regular basis. Kleenex. Coke.
More informationPOINT OF VIEW. Churn management in telecom operators. March, 1st MMC Group s approach in churn management strategies for the telecom sector
POINT OF VIEW March, 1st 2008 MMC Group Strategy Consulting is part of the MMC Group. Headquarters: C/Joaquin Turina, 2 Office 1-2-1, 28224 Pozuelo de Alarcón, Madrid, Spain T +34 91 790 1115 F +34 91
More informationKnow-sweat marketing.
Know-sweat marketing. 20 strategies for 2016 2016 is almost here. As we finish up Q4 and slide in to holiday mode, we need to start to plan for the upcoming year. Here are 20 Know-sweat marketing strategies
More informationLeveraging Audience Segmentation to Build Brand Loyalty David Mickle / Director of Client Services
Leveraging Audience Segmentation to Build Brand Loyalty David Mickle / Director of Client Services Leveraging Audience Segmentation to Build Brand Loyalty Make the case for segmenting audiences to create
More informationWHITE PAPER. Elevating the Health of Healthcare:
WHITE PAPER Elevating the Health of Healthcare: A Four Step Guide In listening to healthcare industry stakeholders describe the difficult and competitive landscape, as has been the case for the past several
More information